Abstract
Objective
The purpose of this study is to compare the effects of cyclic oral dydrogesterone treatment and levonorgestrel-releasing intrauterine device (LNG_IUD) on quality of life (QoL) and sexual function in patients diagnosed with abnormal uterine bleeding (AUB).
Study design
The study was conducted at the University of Health Sciences Turkey Health Istanbul Kanuni Sultan Süleyman Training and Research Hospital, on 171 sexually active patients, aged 18–45, who were under a minimum of 6 months of treatment for AUB. 85 patients were treated with oral cyclic dydrogesterone, and 86 patients received LNG-IUD. Following a minimum of 6 months of treatment, these patients were recruited to the study and were asked to complete a 36-Item Short Form Survey (SF-36) and the Female Sexual Function Index (FSFI).
Results
When the FSFI scores of the patients were compared, it was observed that the total FSFI score was significantly higher in the cyclic dydrogesterone group (p < 0.05). Likewise, it was observed that sexual desire, arousal, and lubrication domains were significantly higher in the cyclic dydrogesterone group (p < 0.05). No significant differences were found between the treatment groups in 7 out of the 8 dimensions of SF-36. The energy/vitality dimension was found to be significantly higher in the cyclic dydrogesterone group.
Conclusion
Total FSFI score, as well as sexual desire, arousal, and lubrication scores, were significantly higher in the cyclic dydrogesterone group compared to the LNG-IUD group indicating that cyclic dydrogesterone has a more positive impact on sexual function when compared to LNG-IUD.
Similar content being viewed by others
Data availability
The dataset used for the current study is available from the corresponding author upon reasonable request.
References
Matthews ML (2015) Abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol Clin North Am 42(1):103–115
Munro MG, Critchley HO, Broder MS, Fraser IS (2011) FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 113(1):3–13
Marnach ML, Laughlin-Tommaso SK (2019) Evaluation and management of abnormal uterine bleeding. Mayo Clin Proc 94(2):326–335
Liu Z, Doan QV, Blumenthal P, Dubois RW (2007) A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 10(3):183–194
Heliövaara-Peippo S, Hurskainen R, Teperi J, Aalto AM, Grénman S, Halmesmäki K et al (2013) Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial. Am J Obstet Gynecol 209(6):535 e1-e14
Benetti-Pinto CL, Rosa ESA, Yela DA, Soares Júnior JM (2017) Abnormal uterine bleeding. Rev Bras Ginecol Obstet 39(7):358–368
Marjoribanks J, Lethaby A, Farquhar C (2006) Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2:Cd003855
Halmesmäki K, Hurskainen R, Teperi J, Grenman S, Kivelä A, Kujansuu E et al (2007) The effect of hysterectomy or levonorgestrel-releasing intrauterine system on sexual functioning among women with menorrhagia: a 5-year randomised controlled trial. BJOG 114(5):563–568
Podzolkova N, Tatarchuk T, Doshchanova A, Eshimbetova G, Pexman-Fieth C (2016) Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study. Gynecol Endocrinol 32(3):246–249
Gorgen H, Api M, Akça A, Cetin A (2009) Use of the levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 279:835–840
Bastianelli C, Farris M, Benagiano G (2011) Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contracept 84(4):402–8
Gupta J, Kai J, Middleton L, Pattison H, Gray R, Daniels J (2013) Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med 368(2):128–137
Yalçın Bahat P, Yücel B, Yuksel Ozgor B, Kadiroğulları P, Topbas Selçuki NF, Çakmak K et al (2022) The effect of dydrogesterone on sexual function in endometriosis. J Obstet Gynaecol 42(5):1276–1279
Backman T (2004) Benefit-risk assessment of the levonorgestrel intrauterine system in contraception. Drug Saf 27(15):1185–1204
Mittermeier T, Farrant C, Wise MR (2020) Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database Syst Rev 9(9):Cd012658
Goshtasebi A, Moukhah S, Gandevani SB (2013) Treatment of heavy menstrual bleeding of endometrial origin: randomized controlled trial of medroxyprogesterone acetate and tranexamic acid. Arch Gynecol Obstet 288(5):1055–1060
Acknowledgements
We thank all our study subjects for participating in this study.
Funding
None received.
Author information
Authors and Affiliations
Contributions
RA: manuscript writing/editing, protocol/project development, data collection or management NFT: data collection or management, manuscript writing/editing, data analysis OK: manuscript writing/editing, data analysis PYB: protocol/project development, data analysis, manuscript writing/editing.
Corresponding author
Ethics declarations
Conflict of interest
No potential conflict of interest was reported by the authors. The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Abul, R., Selcuki, N.F.T., Karadeniz, O. et al. A comparison of the effects of oral dydrogesterone and levonorgestrel-releasing intrauterine device on quality of life and sexual function in patients with abnormal uterine bleeding. Arch Gynecol Obstet 309, 715–719 (2024). https://doi.org/10.1007/s00404-023-07315-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-023-07315-y